Frequency and timing of clinical venous thromboembolism after major joint surgery
- PMID: 16498018
- DOI: 10.1302/0301-620X.88B3.17207
Frequency and timing of clinical venous thromboembolism after major joint surgery
Abstract
Over a 13-year period we studied all patients who underwent major hip and knee surgery and were diagnosed with objectively confirmed symptomatic venous thromboembolism, either deep venous thrombosis or non-fatal pulmonary embolism, within six months after surgery. Low-molecular-weight heparin had been given while the patients were in hospital. There were 5607 patients. The cumulative incidence of symptomatic venous thromboembolism was 2.7% (150 of 5607), of which 1.1% had developed pulmonary embolism, 1.5% had deep venous thrombosis and 0.6% had both. Patients presented with deep venous thrombosis at a median of 24 days and pulmonary embolism at 17 days after surgery for hip fracture. After total hip replacement, deep venous thrombosis and pulmonary embolism occurred at a median of 21 and 34 days respectively. After total knee replacement, the median time to the presentation of deep venous thrombosis and pulmonary embolism was 20 and 12 days respectively. The cumulative risk of venous thromboembolism lasted for up to three months after hip surgery and for one month after total knee replacement. Venous thromboembolism was diagnosed after discharge from hospital in 70% of patients who developed this complication. Despite hospital-based thromboprophylaxis, most cases of clinical venous thromboembolism occur after discharge and at different times according to the operation performed.
Similar articles
-
Economic consequences of venous thromboembolism following major orthopedic surgery.Ann Pharmacother. 2004 Mar;38(3):377-82. doi: 10.1345/aph.1C518. Epub 2004 Jan 12. Ann Pharmacother. 2004. PMID: 14742829
-
Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).Int Angiol. 2006 Dec;25(4):335-42. Int Angiol. 2006. PMID: 17164738 Clinical Trial.
-
Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.Acta Orthop Scand. 2003 Jun;74(3):299-304. doi: 10.1080/00016470310014229. Acta Orthop Scand. 2003. PMID: 12899550
-
Rationale for thromboprophylaxis in lower joint arthroplasty.Am J Orthop (Belle Mead NJ). 2007 Sep;36(9 Suppl):11-3. Am J Orthop (Belle Mead NJ). 2007. PMID: 17948162 Review.
-
Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.Am J Orthop (Belle Mead NJ). 2002 Sep;31(9 Suppl):31-6. Am J Orthop (Belle Mead NJ). 2002. PMID: 12349893 Review.
Cited by
-
Prevalence of relevant early complications during the first 24 h on a normal ward in patients following PACU care after medium and major surgery: a monocentric retrospective observational study.Langenbecks Arch Surg. 2024 Sep 30;409(1):293. doi: 10.1007/s00423-024-03480-z. Langenbecks Arch Surg. 2024. PMID: 39347820 Free PMC article.
-
Comparative efficacy of aspirin versus direct oral anticoagulants for venous thromboembolism prophylaxis following primary total hip arthroplasty or total knee arthroplasty: A systematic review and meta-analysis of randomised controlled trials.J Exp Orthop. 2024 Sep 2;11(3):e70010. doi: 10.1002/jeo2.70010. eCollection 2024 Jul. J Exp Orthop. 2024. PMID: 39224751 Free PMC article. Review.
-
A Comprehensive Review of Risk Factors and Thrombophilia Evaluation in Venous Thromboembolism.J Clin Med. 2024 Jan 9;13(2):362. doi: 10.3390/jcm13020362. J Clin Med. 2024. PMID: 38256496 Free PMC article. Review.
-
Bone Cement Implantation Syndrome: A Rare Disaster Following Cemented Hip Arthroplasties-Clinical Considerations Supported by Case Studies.J Pers Med. 2023 Sep 15;13(9):1381. doi: 10.3390/jpm13091381. J Pers Med. 2023. PMID: 37763149 Free PMC article.
-
Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors.Med Sci (Basel). 2023 Aug 11;11(3):49. doi: 10.3390/medsci11030049. Med Sci (Basel). 2023. PMID: 37606428 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
